Attitudes and Subjective Norms Regarding Medication for Opioid Use Disorder Among Individuals in Treatment for Opioid Use Disorder in the Greater St. Louis Area

Medication for opioid use disorder (MOUD) is safe and efficacious for treating opioid use disorder (OUD), yet there is limited understanding of how attitudes and subjective norms regarding MOUD among individuals with OUD may impede treatment uptake. Thus, the current study describes attitudes and su...

Full description

Saved in:  
Bibliographic Details
Authors: Filiatreau, Lindsey M. (Author) ; Szlyk, Hannah S. (Author) ; Kasson, Erin (Author) ; Dickson, Megan F. (Author) ; Banks, Devin (Author) ; Winograd, Rachel (Author) ; Marotta, Phillip (Author) ; Cavazos-Rehg, Patricia (Author)
Format: Electronic Article
Language:English
Published: 2025
In: Journal of drug issues
Year: 2025, Volume: 55, Issue: 3, Pages: 401-419
Online Access: Volltext (lizenzpflichtig)
Journals Online & Print:
Drawer...
Check availability: HBZ Gateway
Keywords:
theory of planned behavior
intervention stigma
Attitudes
subjective norms
opioid use disorder
medication for opioid use disorder
Description
Summary:Medication for opioid use disorder (MOUD) is safe and efficacious for treating opioid use disorder (OUD), yet there is limited understanding of how attitudes and subjective norms regarding MOUD among individuals with OUD may impede treatment uptake. Thus, the current study describes attitudes and subjective norms in a sample of individuals with OUD in the St. Louis area (N = 183) and compares outcomes among those who were and were not actively taking MOUD. Most endorsed positive views regarding pharmacologic treatment for OUD overall, but concerns about physical side effects, the daily nature of some MOUD options, and uncertainty about the relative risks and benefits of MOUD remained prevalent. Individuals reporting current MOUD use had more accepting attitudes and perceived subjective norms regarding MOUD compared to others, suggesting that interventions targeting improvements in the knowledge of, attitudes toward, and normalization of MOUD are needed to further improve uptake and retention in pharmacotherapy for OUD.
ISSN:1945-1369
DOI:10.1177/00220426241229972